REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropean Metals Holdings Regulatory News (EMH)

Share Price Information for European Metals Holdings (EMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.75
Bid: 22.50
Ask: 23.00
Change: 1.00 (4.60%)
Spread: 0.50 (2.222%)
Open: 21.75
High: 22.75
Low: 21.75
Prev. Close: 21.75
EMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

21 Apr 2016 08:19

RNS Number : 8855V
European Metals Holdings Limited
21 April 2016
 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement, application for quotation of additional securities and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, and 04/03/13

 

 

Name of entity

European Metals Holdings Limited

 

 

ARBN

 

 55 154 618 989

 

 

We (the entity) give ASX the following information.

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

CHESS Depository Interests (CDI)

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

3,525

 

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

CDI's

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

 

 

5

Issue price or consideration

 

$0.10

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Exercise of Listed Options (EMHO)

 

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

No

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

Nil

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

Nil

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

Nil

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Nil

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

7.1 58,293

7.1A N/A

 

 

 

7 7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

20 April 2016

 

 

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

100,055,287

 

21,939,498

CDIs

 

Options - 10 cents exercise price expiring at 5.00pm (WST) on 30 June 2016

 

 

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

3,750,000

Options - 16.6 cents exercise price expiring on 17 August 2020

 

2,000,000

Options - 20 cents exercise price expiring on 19 October 2016

 

5,000,000

Class B Performance Shares

1,00,000

Warrants - 14 cents exercise price expiring at 5.00pm (WST) on 11 November 2018

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

The Company does not currently have a dividend policy.

 

Part 2 ‑ Pro rata issue

11

Is security holder approval required?

 

N/A

 

 

 

12

Is the issue renounceable ornon-renounceable?

N/A

 

 

 

13

Ratio in which the +securities will be offered

N/A

 

 

 

14

+Class of +securities to which the offer relates

N/A

 

 

 

15

+Record date to determine entitlements

 

N/A

 

 

 

16

Will holdings on different registers (or sub-registers) be aggregated for calculating entitlements?

N/A

 

 

 

17

Policy for deciding entitlements in relation to fractions

N/A

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

 

 

 

19

Closing date for receipt of acceptances or renunciations

N/A

 

 

 

20

Names of any underwriters

 

N/A

 

 

 

21

Amount of any underwriting fee or commission

N/A

 

 

 

22

Names of any brokers to the issue

N/A

 

 

 

23

Fee or commission payable to the broker to the issue

N/A

 

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

 

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

N/A

 

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

N/A

 

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

 

 

 

28

Date rights trading will begin (if applicable)

N/A

 

 

 

29

Date rights trading will end (if applicable)

N/A

 

 

 

30

How do security holders sell their entitlements in full through a broker?

N/A

 

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

 

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

N/A

 

 

 

33

+Issue date

N/A

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34

Type of +securities

(tick one)

(a)

+Securities described in Part 1

 

 

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

Additional securities forming a new class of securitiesTick to indicate you are providing the information or documents

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

 

37

A copy of any trust deed for the additional +securities

 

Entities that have ticked box 34(b)

38

Number of +securities for which +quotation is sought

 

 

 

39

+Class of +securities for which quotation is sought

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another +security, clearly identify that other +security)

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

 

Quotation agreement

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

2 We warrant the following to ASX.

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

· There is no reason why those +securities should not be granted +quotation.

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

 

 

 

Sign here:

 

Date:

21 April 2016

 

Print name: Julia Beckett

Company Secretary

== == == == ==

 

 

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital

STEP 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

38,400,006

Add the following:

 

· Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

23,942,860

· Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

24,708,896

· Number of partly paid ordinary securities that became fully paid in that 12 month period

3,525

Note:

Include only ordinary securities here - other classes of equity securities cannot be added

Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

It may be useful to set out issues of securities on different dates as separate line items

 

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

"A"

87,055,287

STEP 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

13,058,293

STEP 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

· Under an exception in rule 7.2

· Under rule 7.1A

· With security holder approval under rule 7.1 or rule 7.4

Note:

· This applies to equity securities, unless specifically excluded - not just ordinary securities

· Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

· It may be useful to set out issues of securities on different dates as separate line items

13,000,000

"C"

13,000,000

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

13,058,293

Subtract "C"

Note: number must be same as shown in Step 3

13,000,000

Total ["A" x 0.15] - "C"

58,293

[Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

N/A

Step 2: Calculate 10% of "A"

"D"

0.10

[Note: this value cannot be changed]

Multiply "A" by 0.10

 

N/A

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

· This applies to equity securities - not just ordinary securities

· Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

· Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

· It may be useful to set out issues of securities on different dates as separate line items

N/A

"E"

 

nil

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

N/A

Subtract "E"

Note: number must be same as shown in Step 3

nil

Total ["A" x 0.10] - "E"

 

nil

[Note: this is the remaining placement capacity under rule 7.1A]

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CONUAABRNBASURR
Date   Source Headline
7th May 202410:00 amRNSSchedule One Update - European Metals Holdings Ltd
7th May 20249:22 amRNSNew Constitution
7th May 20249:12 amRNSRedomiciliation Update
30th Apr 20248:40 amRNSQuarterly Report
30th Apr 20248:00 amRNSSchedule One Update - European Metals Holdings Ltd
29th Apr 20248:00 amRNSSchedule One Update - European Metals Holdings Ltd
25th Apr 20247:23 amRNSNew Plant Site to Improve Project Permitting&Econ
18th Apr 20241:29 pmRNSAppointment of Director - Replacement
18th Apr 20248:12 amRNSAppointment of Director
11th Apr 20247:00 amRNSSuccessful Production of Lithium Hydroxide
4th Apr 20248:00 amRNSSchedule One - European Metals Holdings Limited
28th Mar 20247:50 amRNSIssue of Equity
27th Mar 20247:00 amRNSCinovec Project Update
15th Mar 20247:59 amRNSHalf-year Report
14th Feb 20249:18 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSQuarterly Report
29th Jan 20247:00 amRNSExtension Granted for Cinovec Exploration Licenses
22nd Dec 20238:05 amRNSResult of AGM
22nd Dec 20237:00 amRNSCinovec DFS to be Completed in Q1 2024
1st Dec 20237:00 amRNSNotice of AGM
9th Nov 20237:00 amRNSSuccessful Battery Grade pilot - Cinovec Project
31st Oct 20239:24 amRNSQuarterly Report
25th Oct 20239:42 amRNSIssue of Equity
20th Oct 20239:41 amRNSIssue of Equity
7th Sep 202310:34 amRNSIssue of Equity
1st Sep 20238:07 amRNSTR-1 Notification of Major Holdings
23rd Aug 202310:29 amRNSCirc re. Equity Issue
10th Aug 20232:45 pmRNSCirc re. Option Issue
9th Aug 202312:51 pmRNSCirc re.Option Cessation
9th Aug 202310:40 amRNSDirector/PDMR Shareholding
31st Jul 20239:26 amRNSDoc re. Quarterly Report 30 June 2023
21st Jul 20237:53 amRNSEBRD Strategic Investment in EMH
9th Jun 20237:00 amRNSLand Secured for Cinovec Lithium Plant
2nd Jun 20237:00 amRNSInvestor Webinar Presentation
25th May 20237:00 amRNSTestwork Realises Outstanding Lithium Recoveries
18th May 20237:00 amRNSCzech PM visits Cinovec, signs MoC with Saxony PM
28th Apr 20239:29 amRNSDoc re. Quarterly Report 31 Mar 2023
20th Apr 20237:00 amRNSCompany Secretary Change
6th Apr 20237:00 amRNSInvestor Presentation
16th Mar 20237:00 amRNSHalf-year Report
2nd Feb 20237:00 amRNSDRA Global appointed to complete DFS for Cinovec
31st Jan 20238:06 amRNSDoc re. (Quarterly Activities Report 31 Dec 2022)
30th Jan 20237:00 amRNSJust Transition Fund Approves Cinovec Project
9th Jan 20237:00 amRNSIssue of Equity
25th Nov 20228:50 amRNSNotice of Annual General Meeting Results
10th Nov 20227:00 amRNSLithium Specialist Marc Rowley to join EMH/Cinovec
9th Nov 20229:17 amRNSNotice of Annual General Meeting
8th Nov 20227:00 amRNSInvestor Presentation
7th Nov 20228:30 amRNSChange of Director's Interest Notice
31st Oct 202210:02 amRNSQuarterly Activities and Cash Flow Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.